Genomics

Dataset Information

0

Selective Elimination of Immunosuppressive T cells in Patients with Multiple Myeloma


ABSTRACT: Elimination of suppressive T cells may enable and enhance cancer immunotherapy. Here, we demonstrate that the cell membrane protein SLAMF7 was highly expressed on immunosuppressive CD8+CD28-CD57+ Tregs in multiple myeloma (MM). SLAMF7 expression associated with T cell exhaustion surface markers and exhaustion-related transcription factor signatures. T cells from patients with a high frequency of SLAMF7+CD8+ T cells exhibited decreased immunoreactivity towards the MART-1aa26–35*A27L antigen. A monoclonal anti-SLAMF7 antibody (elotuzumab) specifically depleted SLAMF7+CD8+ T cells in vitro and in vivo via macrophage-mediated antibody-dependent cellular phagocytosis (ADCP). Anti-SLAMF7 treatment of MM patients depleted suppressive T cells in peripheral blood. These data highlight SLAMF7 as a marker for suppressive CD8+ Treg and suggest that anti-SLAMF7 antibodies can be used to boost anti-tumoral immune responses in cancer patients.

PROVIDER: EGAS00001004915 | EGA |

REPOSITORIES: EGA

Similar Datasets

2016-04-03 | E-GEOD-79858 | biostudies-arrayexpress
2013-10-30 | E-GEOD-51849 | biostudies-arrayexpress
2016-07-01 | E-GEOD-73001 | biostudies-arrayexpress
2022-02-20 | E-MTAB-11441 | biostudies-arrayexpress
2016-06-14 | E-GEOD-79475 | biostudies-arrayexpress
2016-07-01 | E-GEOD-51489 | biostudies-arrayexpress
2010-12-09 | E-GEOD-25890 | biostudies-arrayexpress
2012-07-09 | E-GEOD-39205 | biostudies-arrayexpress
2022-11-10 | GSE199177 | GEO
2014-07-13 | E-GEOD-58078 | biostudies-arrayexpress